Leydig and Sertoli cell function in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion
a case-control study
Keywords:
Inhibin B [supplementary concept], Disorders of sex development, Sertoli cells, Leydig cellsAbstract
BACKGROUND: Because normal male sexual differentiation is more complex than normal female sexual differentiation, there are more cases of disorders of sex development (DSDs) with 46,XY karyotype that have unclear etiology. However, Leydig and Sertoli cell markers are rarely used in distinguishing such individuals. OBJECTIVES: To evaluate the function of Leydig and Sertoli cells in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion. STUDY DESIGN AND SETTING: Case-control study with 77 patients, including eight with partial androgen insensitivity syndrome, eight with 5α-reductase deficiency type 2 (5ARD2) and 19 with idiopathic 46,XY DSD, and 42 healthy controls, from the Interdisciplinary Study Group for Sex Determination and Differentiation (GIEDDS), at the State University of Campinas (UNICAMP), Campinas, Brazil. METHODS: Baseline levels of gonadotropins, anti-Müllerian hormone (AMH), inhibin B, insulin-like 3 (INSL3), testosterone and dihydrotestosterone in cases, and AMH, inhibin B, and INSL3 levels in controls, were assessed. RESULTS: There was no significant difference in age between cases and controls (P = 0.595). AMH and inhibin B levels were significantly lower in cases than in controls (P = 0.031 and P < 0.001, respectively). INSL3 levels were significantly higher in cases than in controls (P = 0.003). Inhibin B levels were lower in 5ARD2 patients (P = 0.045) and idiopathic patients (P = 0.001), in separate comparisons with the controls. CONCLUSION: According to our findings, we can speculate that inhibin B levels may be used to differentiate among DSD cases.
Downloads
References
Lee PA, Houk CP, Ahmed SF, Hughes IA; International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006;118(2):e488-500. PMID: 16882788; https://doi.org/10.1542/peds.2006-0738
Veiga-Junior NN, Medaets PA, Petroli RJ, et al. Clinical and Laboratorial Features That May Differentiate 46,XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency. Int J Endocrinol. 2012;2012:964876. PMID: 22194745; https://doi.org/10.1155/2012/964876
Ahmed SF, Achermann JC, Arlt W, et al. Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015). Clin Endocrinol (Oxf). 2016;84(5):771-88. PMID: 26270788; https://doi.org/10.1111/cen.12857
Freire AV, Grinspon RP, Rey RA. Importance of Serum Testicular Protein Hormone Measurement in the Assessment of Disorders of Sex Development. Sex Dev. 2018;12(1-3):30-40. PMID: 28850950; https://doi.org/10.1159/000479572
Rey R, Mebarki F, Forest MG, et al. Anti-müllerian hormone in children with androgen insensitivity. J Clin Endocrinol Metab. 1994;79(4):960-4. PMID: 7962305; https://doi.org/10.1210/jcem.79.4.7962305
Rey RA, Belville C, Nihoul-Fékété C, et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab. 1999;84(2):627-31. PMID: 10022428; https://doi.org/10.1210/jcem.84.2.5507
Bouvattier C, Mignot B, Lefèvre H, Morel Y, Bougnères P. Impaired sexual activity in male adults with partial androgen insensitivity. J Clin Endocrinol Metab. 2006;91(9):3310-5. PMID: 16757528; https://doi.org/10.1210/jc.2006-0218
Stuchi-Perez EG, Lukas-Croisier C, De Castro M, et al. Evaluation of the tubular and interstitial functions of the testis in 46,XY patients with ambiguous genitalia. J Pediatr Endocrinol Metab. 2000;13(6):605-12. PMID: 10905384; https://doi.org/10.1515/jpem.2000.13.6.605
Stuchi-Perez EG, Hackel C, Oliveira LE, et al. Diagnosis of 5alpha-reductase type 2 deficiency: contribution of anti-Müllerian hormone evaluation. J Pediatr Endocrinol Metab. 2005;18(12):1383-9. PMID: 16459464; https://doi.org/10.1515/jpem.2005.18.12.1383
De Paula GB, Barros BA, Carpini S, et al. 408 Cases of Genital Ambiguity Followed by Single Multidisciplinary Team during 23 Years: Etiologic Diagnosis and Sex of Rearing. Int J Endocrinol. 2016;2016:4963574. PMID: 28018429; https://doi.org/10.1155/2016/4963574
Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int. 2000;85(1):120-4. PMID: 10619959; https://doi.org/10.1046/j.1464-410x.2000.00354.x
Segal TY, Mehta A, Anazodo A, Hindmarsh PC, Dattani MT. Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. J Clin Endocrinol Metab. 2009;94(3):780-5. https://doi.org/10.1210/jc.2008-0302
Mendonca BB, Billerbeck AE, de Zegher F. Nongenetic male pseudohermaphroditism and reduced prenatal growth. N Engl J Med. 2001;345(15):1135. PMID: 11596604; https://doi.org/10.1056/NEJM200110113451518
Morel Y, Rey R, Teinturier C, et al. Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr. 2002;161(1):49-59. PMID: 11808880; https://doi.org/10.1007/s00431-001-0854-z
de Andrade Machado Neto F, Moreno Morcillo A, Trevas Maciel-Guerra A, Guerra-Junior G. Idiopathic male pseudohermaphroditism is associated with prenatal growth retardation. Eur J Pediatr. 2005;164(5):287-91. PMID: 15711770; https://doi.org/10.1007/s00431-005-1626-y
Kulle AE, Riepe FG, Melchior D, Hiort O, Holterhus PM. A novel ultrapressure liquid chromatography tandem mass spectrometry method for the simultaneous determination of androstenedione, testosterone, and dihydrotestosterone in pediatric blood samples: age- and sex-specific reference data. J Clin Endocrinol Metab. 2010;95(5):2399-409. PMID: 20200336; https://doi.org/10.1210/jc.2009-1670
Krone N, Hughes BA, Lavery GG, et al. Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol. 2010;121(3-5):496-504. PMID: 20417277; https://doi.org/10.1016/j.jsbmb.2010.04.010
Chan AO, But BW, Lee CY, et al. Diagnosis of 5α-reductase 2 deficiency: is measurement of dihydrotestosterone essential? Clin Chem. 2013;59(5):798-806. PMID: 23513070; https://doi.org/10.1373/clinchem.2012.196501
Lee PA, Nordenström A, Houk CP, et al. Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care. Horm Res Paediatr. 2016;85(3):158-80. PMID: 26820577; https://doi.org/10.1159/000442975 Erratum in: Horm Res Paediatr. 2016;85(3):180. Koopman, Peter [added]. Erratum in: Horm Res Paediatr. 2016;86(1):70.
Blanc T, Ayedi A, El-Ghoneimi A, et al. Testicular function and physical outcome in young adult males diagnosed with idiopathic 46 XY disorders of sex development during childhood. Eur J Endocrinol. 2011;165(6):907-15. PMID: 21964959; https://doi.org/10.1530/EJE-11-0588
Crofton PM, Evans AE, Groome NP, et al. Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin Endocrinol (Oxf). 2002;56(2):215-21. PMID: 11874413; https://doi.org/10.1046/j.0300-0664.2001.01448.x
Kollin C, Stukenborg JB, Nurmio M, et al. Boys with undescended testes: endocrine, volumetric and morphometric studies on testicular function before and after orchidopexy at nine months or three years of age. J Clin Endocrinol Metab. 2012;97(12):4588-95. PMID: 23015652; https://doi.org/10.1210/jc.2012-2325
Thorup J, Clasen-Linde E, Thorup SC, Cortes D. Pre- and postoperative status of gonadotropins (FSH and LH) and inhibin-B in relation to testicular histopathology at orchiopexy in infant boys with unilateral undescended testes. J Pediatr Urol. 2015;11(1):25.e1-5. PMID: 25267218; https://doi.org/10.1016/j.jpurol.2014.08.007
Kumanov P, Nandipati K, Tomova A, Agarwal A. Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility. Fertil Steril. 2006;86(2):332-8. PMID: 16764873; https://doi.org/10.1016/j.fertnstert.2006.01.022
Jørgensen N, Liu F, Andersson AM, et al. Serum inhibin-b in fertile men is strongly correlated with low but not high sperm counts: a coordinated study of 1,797 European and US men. Fertil Steril. 2010;94(6):2128-34. PMID: 20149358; https://doi.org/10.1016/j.fertnstert.2009.12.051
Barbotin AL, Ballot C, Sigala J, et al. The serum inhibin B concentration and reference ranges in normozoospermia. Eur J Endocrinol. 2015;172(6):669-76. PMID: 25740852; https://doi.org/10.1530/EJE-14-0932
Juniarto AZ, van der Zwan YG, Santosa A, et al. Hormonal evaluation in relation to phenotype and genotype in 286 patients with a disorder of sex development from Indonesia. Clin Endocrinol (Oxf). 2016;85(2):247-57. PMID: 26935236; https://doi.org/10.1111/cen.13051
Fabbri HC, de Andrade JG, Soardi FC, et al. The novel p.Cys65Tyr mutation in NR5A1 gene in three 46,XY siblings with normal testosterone levels and their mother with primary ovarian insufficiency. BMC Med Genet. 2014;15:7. PMID: 24405868; https://doi.org/10.1186/1471-2350-15-7
Byrd W, Bennett MJ, Carr BR, et al. Regulation of biologically active dimeric inhibin A and B from infancy to adulthood in the male. J Clin Endocrinol Metab. 1998;83(8):2849-54. PMID: 9709958; https://doi.org/10.1210/jcem.83.8.5008
Wallace EM, Riley SC, Crossley JA, et al. Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. J Clin Endocrinol Metab. 1997;82(1):218-22. PMID: 8989262; https://doi.org/10.1210/jcem.82.1.3685
De Schepper J, Verlinde F, Cortvrindt R, Callewaert M, Smitz J. Serum inhibin B in normal term-born male and female neonates during the first week of life. Eur J Pediatr. 2000;159(6):465-9. PMID: 10867856; https://doi.org/10.1007/s004310051309
Kang HJ, Imperato-McGinley J, Zhu YS, Rosenwaks Z. The effect of 5α-reductase-2 deficiency on human fertility. Fertil Steril. 2014;101(2):310-6. PMID: 24412121; https://doi.org/10.1016/j.fertnstert.2013.11.128
Vija L, Ferlicot S, Paun D, et al. Testicular histological and immunohistochemical aspects in a post-pubertal patient with 5 alpha-reductase type 2 deficiency: case report and review of the literature in a perspective of evaluation of potential fertility of these patients. BMC Endocr Disord. 2014;14:43. PMID: 24885102; https://doi.org/10.1186/1472-6823-14-43
Anand-Ivell R, Cohen A, Nørgaard-Pedersen B, et al. Amniotic Fluid INSL3 Measured During the Critical Time Window in Human Pregnancy Relates to Cryptorchidism, Hypospadias, and Phthalate Load: A Large Case-Control Study. Front Physiol. 2018;9:406. PMID: 29740335; https://doi.org/10.3389/fphys.2018.00406
Ivell R, Anand-Ivell R. Biology of insulin-like factor 3 in human reproduction. Hum Reprod Update. 2009;15(4):463-76. PMID: 19329805; https://doi.org/10.1093/humupd/dmp011
Ivell R, Wade JD, Anand-Ivell R. INSL3 as a biomarker of Leydig cell functionality. Biol Reprod. 2013;88(6):147. PMID: 23595905; https://doi.org/10.1095/biolreprod.113.108969
Hiort O, Holterhus PM. Androgen insensitivity and male infertility. Int J Androl. 2003;26(1):16-20. PMID: 12534933; https://doi.org/10.1046/j.1365-2605.2003.00369.x
Marumudi E, Ammini AC. Fertility in patients with 5-alpha-reductase-2 deficiency. Fertil Steril. 2011;95(7):e45; author reply e46. PMID: 21497347; https://doi.org/10.1016/j.fertnstert.2011.03.076
Wang RS, Yeh S, Tzeng CR, Chang C. Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. Endocr Rev. 2009;30(2):119-32. PMID: 19176467; https://doi.org/10.1210/er.2008-0025
